SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-18-124946
Filing Date
2018-04-20
Accepted
2018-04-20 16:24:02
Documents
1
Effectiveness Date
2018-04-20

Document Format Files

Seq Description Document Type Size
1 NOTICE & ACCESS d567769ddefa14a.htm DEFA14A 26401
  Complete submission text file 0001193125-18-124946.txt   27595
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Filer) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36500 | Film No.: 18766956
SIC: 2834 Pharmaceutical Preparations